nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—ABCC1—Rosuvastatin—atherosclerosis	0.149	0.22	CbGbCtD
Mitoxantrone—ABCG2—Rosuvastatin—atherosclerosis	0.0999	0.147	CbGbCtD
Mitoxantrone—ABCG2—Ezetimibe—atherosclerosis	0.0999	0.147	CbGbCtD
Mitoxantrone—ABCG2—Pravastatin—atherosclerosis	0.0909	0.134	CbGbCtD
Mitoxantrone—ABCB1—Ezetimibe—atherosclerosis	0.036	0.0532	CbGbCtD
Mitoxantrone—ABCB1—Simvastatin—atherosclerosis	0.0335	0.0494	CbGbCtD
Mitoxantrone—ABCB1—Pravastatin—atherosclerosis	0.0328	0.0484	CbGbCtD
Mitoxantrone—ABCB1—Lovastatin—atherosclerosis	0.0328	0.0484	CbGbCtD
Mitoxantrone—CYP3A4—Ezetimibe—atherosclerosis	0.0216	0.0318	CbGbCtD
Mitoxantrone—CYP3A4—Rosuvastatin—atherosclerosis	0.0216	0.0318	CbGbCtD
Mitoxantrone—CYP3A4—Simvastatin—atherosclerosis	0.0201	0.0296	CbGbCtD
Mitoxantrone—CYP3A4—Pravastatin—atherosclerosis	0.0196	0.029	CbGbCtD
Mitoxantrone—CYP3A4—Lovastatin—atherosclerosis	0.0196	0.029	CbGbCtD
Mitoxantrone—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.00159	0.343	CbGdCrCtD
Mitoxantrone—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00152	0.328	CbGdCrCtD
Mitoxantrone—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00152	0.328	CbGdCrCtD
Mitoxantrone—BTK—connective tissue—atherosclerosis	0.00121	0.114	CbGeAlD
Mitoxantrone—PIM1—connective tissue—atherosclerosis	0.00105	0.0986	CbGeAlD
Mitoxantrone—BTK—adipose tissue—atherosclerosis	0.000927	0.0874	CbGeAlD
Mitoxantrone—PIM1—cardiovascular system—atherosclerosis	0.000911	0.0858	CbGeAlD
Mitoxantrone—PIM1—adipose tissue—atherosclerosis	0.000803	0.0757	CbGeAlD
Mitoxantrone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000776	0.0045	CcSEcCtD
Mitoxantrone—Sinusitis—Lovastatin—atherosclerosis	0.000769	0.00446	CcSEcCtD
Mitoxantrone—Sweating increased—Pravastatin—atherosclerosis	0.000757	0.00439	CcSEcCtD
Mitoxantrone—Sinusitis—Ezetimibe—atherosclerosis	0.000754	0.00437	CcSEcCtD
Mitoxantrone—Jaundice—Simvastatin—atherosclerosis	0.000747	0.00433	CcSEcCtD
Mitoxantrone—Hepatitis—Lovastatin—atherosclerosis	0.000736	0.00427	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Niacin—atherosclerosis	0.000727	0.00422	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000722	0.00419	CcSEcCtD
Mitoxantrone—Hepatitis—Ezetimibe—atherosclerosis	0.000722	0.00418	CcSEcCtD
Mitoxantrone—Sinusitis—Simvastatin—atherosclerosis	0.000719	0.00417	CcSEcCtD
Mitoxantrone—Pharyngitis—Ezetimibe—atherosclerosis	0.000716	0.00415	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Pravastatin—atherosclerosis	0.000716	0.00415	CcSEcCtD
Mitoxantrone—Weight increased—Pravastatin—atherosclerosis	0.000707	0.0041	CcSEcCtD
Mitoxantrone—Weight decreased—Pravastatin—atherosclerosis	0.000703	0.00408	CcSEcCtD
Mitoxantrone—Hepatitis—Simvastatin—atherosclerosis	0.000688	0.00399	CcSEcCtD
Mitoxantrone—Stomatitis—Niacin—atherosclerosis	0.000686	0.00398	CcSEcCtD
Mitoxantrone—Jaundice—Niacin—atherosclerosis	0.000686	0.00398	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000683	0.00396	CcSEcCtD
Mitoxantrone—Myocardial infarction—Pravastatin—atherosclerosis	0.000679	0.00394	CcSEcCtD
Mitoxantrone—Jaundice—Pravastatin—atherosclerosis	0.000676	0.00392	CcSEcCtD
Mitoxantrone—Sweating—Niacin—atherosclerosis	0.000675	0.00391	CcSEcCtD
Mitoxantrone—Urinary tract infection—Pravastatin—atherosclerosis	0.000674	0.00391	CcSEcCtD
Mitoxantrone—Chills—Lovastatin—atherosclerosis	0.00066	0.00383	CcSEcCtD
Mitoxantrone—Cough—Rosuvastatin—atherosclerosis	0.000659	0.00382	CcSEcCtD
Mitoxantrone—BTK—liver—atherosclerosis	0.00065	0.0613	CbGeAlD
Mitoxantrone—Sinusitis—Pravastatin—atherosclerosis	0.00065	0.00377	CcSEcCtD
Mitoxantrone—Alopecia—Lovastatin—atherosclerosis	0.00065	0.00377	CcSEcCtD
Mitoxantrone—Arthralgia—Rosuvastatin—atherosclerosis	0.000643	0.00373	CcSEcCtD
Mitoxantrone—Myalgia—Rosuvastatin—atherosclerosis	0.000643	0.00373	CcSEcCtD
Mitoxantrone—Alopecia—Ezetimibe—atherosclerosis	0.000638	0.0037	CcSEcCtD
Mitoxantrone—Haemoglobin—Niacin—atherosclerosis	0.000635	0.00368	CcSEcCtD
Mitoxantrone—Rhinitis—Niacin—atherosclerosis	0.000633	0.00367	CcSEcCtD
Mitoxantrone—Haemorrhage—Niacin—atherosclerosis	0.000632	0.00366	CcSEcCtD
Mitoxantrone—Hepatitis—Niacin—atherosclerosis	0.000632	0.00366	CcSEcCtD
Mitoxantrone—Erythema—Ezetimibe—atherosclerosis	0.000628	0.00364	CcSEcCtD
Mitoxantrone—Dysgeusia—Lovastatin—atherosclerosis	0.000627	0.00364	CcSEcCtD
Mitoxantrone—Rhinitis—Pravastatin—atherosclerosis	0.000624	0.00362	CcSEcCtD
Mitoxantrone—Hepatitis—Pravastatin—atherosclerosis	0.000622	0.00361	CcSEcCtD
Mitoxantrone—Confusional state—Rosuvastatin—atherosclerosis	0.000622	0.00361	CcSEcCtD
Mitoxantrone—Back pain—Lovastatin—atherosclerosis	0.000619	0.00359	CcSEcCtD
Mitoxantrone—Pharyngitis—Pravastatin—atherosclerosis	0.000617	0.00358	CcSEcCtD
Mitoxantrone—Chills—Simvastatin—atherosclerosis	0.000617	0.00358	CcSEcCtD
Mitoxantrone—Infection—Rosuvastatin—atherosclerosis	0.000613	0.00355	CcSEcCtD
Mitoxantrone—Alopecia—Simvastatin—atherosclerosis	0.000608	0.00353	CcSEcCtD
Mitoxantrone—Back pain—Ezetimibe—atherosclerosis	0.000608	0.00352	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000604	0.0035	CcSEcCtD
Mitoxantrone—Vision blurred—Lovastatin—atherosclerosis	0.000604	0.0035	CcSEcCtD
Mitoxantrone—Erythema—Simvastatin—atherosclerosis	0.000599	0.00347	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000594	0.00345	CcSEcCtD
Mitoxantrone—Dysgeusia—Simvastatin—atherosclerosis	0.000587	0.0034	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000583	0.00338	CcSEcCtD
Mitoxantrone—Anaemia—Ezetimibe—atherosclerosis	0.000581	0.00337	CcSEcCtD
Mitoxantrone—Malaise—Lovastatin—atherosclerosis	0.000578	0.00335	CcSEcCtD
Mitoxantrone—Leukopenia—Lovastatin—atherosclerosis	0.000573	0.00332	CcSEcCtD
Mitoxantrone—Chills—Niacin—atherosclerosis	0.000567	0.00329	CcSEcCtD
Mitoxantrone—Malaise—Ezetimibe—atherosclerosis	0.000566	0.00328	CcSEcCtD
Mitoxantrone—Vision blurred—Simvastatin—atherosclerosis	0.000565	0.00327	CcSEcCtD
Mitoxantrone—Arrhythmia—Niacin—atherosclerosis	0.000564	0.00327	CcSEcCtD
Mitoxantrone—PIM1—liver—atherosclerosis	0.000563	0.0531	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000562	0.00326	CcSEcCtD
Mitoxantrone—Alopecia—Niacin—atherosclerosis	0.000558	0.00324	CcSEcCtD
Mitoxantrone—Chills—Pravastatin—atherosclerosis	0.000558	0.00324	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000556	0.00322	CcSEcCtD
Mitoxantrone—Arrhythmia—Pravastatin—atherosclerosis	0.000556	0.00322	CcSEcCtD
Mitoxantrone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000554	0.00321	CcSEcCtD
Mitoxantrone—Anaemia—Simvastatin—atherosclerosis	0.000554	0.00321	CcSEcCtD
Mitoxantrone—Erythema—Niacin—atherosclerosis	0.00055	0.00319	CcSEcCtD
Mitoxantrone—Alopecia—Pravastatin—atherosclerosis	0.00055	0.00319	CcSEcCtD
Mitoxantrone—Cough—Ezetimibe—atherosclerosis	0.000548	0.00318	CcSEcCtD
Mitoxantrone—Chest pain—Lovastatin—atherosclerosis	0.000545	0.00316	CcSEcCtD
Mitoxantrone—Myalgia—Lovastatin—atherosclerosis	0.000545	0.00316	CcSEcCtD
Mitoxantrone—Arthralgia—Lovastatin—atherosclerosis	0.000545	0.00316	CcSEcCtD
Mitoxantrone—Anxiety—Lovastatin—atherosclerosis	0.000543	0.00315	CcSEcCtD
Mitoxantrone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000543	0.00315	CcSEcCtD
Mitoxantrone—Hypertension—Ezetimibe—atherosclerosis	0.000542	0.00314	CcSEcCtD
Mitoxantrone—Malaise—Simvastatin—atherosclerosis	0.00054	0.00313	CcSEcCtD
Mitoxantrone—Discomfort—Lovastatin—atherosclerosis	0.000539	0.00312	CcSEcCtD
Mitoxantrone—Leukopenia—Simvastatin—atherosclerosis	0.000536	0.00311	CcSEcCtD
Mitoxantrone—Chest pain—Ezetimibe—atherosclerosis	0.000535	0.0031	CcSEcCtD
Mitoxantrone—Arthralgia—Ezetimibe—atherosclerosis	0.000535	0.0031	CcSEcCtD
Mitoxantrone—Myalgia—Ezetimibe—atherosclerosis	0.000535	0.0031	CcSEcCtD
Mitoxantrone—Dysgeusia—Pravastatin—atherosclerosis	0.00053	0.00307	CcSEcCtD
Mitoxantrone—Discomfort—Ezetimibe—atherosclerosis	0.000528	0.00306	CcSEcCtD
Mitoxantrone—Pain—Rosuvastatin—atherosclerosis	0.000527	0.00306	CcSEcCtD
Mitoxantrone—Constipation—Rosuvastatin—atherosclerosis	0.000527	0.00306	CcSEcCtD
Mitoxantrone—Confusional state—Lovastatin—atherosclerosis	0.000527	0.00306	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000523	0.00303	CcSEcCtD
Mitoxantrone—Infection—Lovastatin—atherosclerosis	0.000519	0.00301	CcSEcCtD
Mitoxantrone—Vision blurred—Niacin—atherosclerosis	0.000518	0.00301	CcSEcCtD
Mitoxantrone—Confusional state—Ezetimibe—atherosclerosis	0.000517	0.003	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000513	0.00297	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000512	0.00297	CcSEcCtD
Mitoxantrone—Vision blurred—Pravastatin—atherosclerosis	0.00051	0.00296	CcSEcCtD
Mitoxantrone—Myalgia—Simvastatin—atherosclerosis	0.00051	0.00296	CcSEcCtD
Mitoxantrone—Chest pain—Simvastatin—atherosclerosis	0.00051	0.00296	CcSEcCtD
Mitoxantrone—Arthralgia—Simvastatin—atherosclerosis	0.00051	0.00296	CcSEcCtD
Mitoxantrone—Infection—Ezetimibe—atherosclerosis	0.000509	0.00295	CcSEcCtD
Mitoxantrone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000508	0.00295	CcSEcCtD
Mitoxantrone—Anxiety—Simvastatin—atherosclerosis	0.000508	0.00295	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000504	0.00292	CcSEcCtD
Mitoxantrone—Discomfort—Simvastatin—atherosclerosis	0.000504	0.00292	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000502	0.00291	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000502	0.00291	CcSEcCtD
Mitoxantrone—Anaemia—Pravastatin—atherosclerosis	0.000501	0.0029	CcSEcCtD
Mitoxantrone—Anorexia—Lovastatin—atherosclerosis	0.000498	0.00289	CcSEcCtD
Mitoxantrone—Skin disorder—Ezetimibe—atherosclerosis	0.000498	0.00289	CcSEcCtD
Mitoxantrone—Confusional state—Simvastatin—atherosclerosis	0.000493	0.00286	CcSEcCtD
Mitoxantrone—Leukopenia—Niacin—atherosclerosis	0.000492	0.00285	CcSEcCtD
Mitoxantrone—Urticaria—Rosuvastatin—atherosclerosis	0.00049	0.00284	CcSEcCtD
Mitoxantrone—Oedema—Simvastatin—atherosclerosis	0.000489	0.00283	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000489	0.00283	CcSEcCtD
Mitoxantrone—Malaise—Pravastatin—atherosclerosis	0.000488	0.00283	CcSEcCtD
Mitoxantrone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000488	0.00283	CcSEcCtD
Mitoxantrone—Infection—Simvastatin—atherosclerosis	0.000486	0.00282	CcSEcCtD
Mitoxantrone—Leukopenia—Pravastatin—atherosclerosis	0.000485	0.00281	CcSEcCtD
Mitoxantrone—Cough—Niacin—atherosclerosis	0.00048	0.00278	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000479	0.00278	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000476	0.00276	CcSEcCtD
Mitoxantrone—Cough—Pravastatin—atherosclerosis	0.000473	0.00274	CcSEcCtD
Mitoxantrone—TOP2A—adipose tissue—atherosclerosis	0.000471	0.0444	CbGeAlD
Mitoxantrone—Paraesthesia—Lovastatin—atherosclerosis	0.000469	0.00272	CcSEcCtD
Mitoxantrone—Arthralgia—Niacin—atherosclerosis	0.000468	0.00272	CcSEcCtD
Mitoxantrone—Myalgia—Niacin—atherosclerosis	0.000468	0.00272	CcSEcCtD
Mitoxantrone—Hypertension—Pravastatin—atherosclerosis	0.000468	0.00271	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000467	0.00271	CcSEcCtD
Mitoxantrone—Anorexia—Simvastatin—atherosclerosis	0.000466	0.0027	CcSEcCtD
Mitoxantrone—Dyspnoea—Lovastatin—atherosclerosis	0.000466	0.0027	CcSEcCtD
Mitoxantrone—Arthralgia—Pravastatin—atherosclerosis	0.000461	0.00267	CcSEcCtD
Mitoxantrone—Chest pain—Pravastatin—atherosclerosis	0.000461	0.00267	CcSEcCtD
Mitoxantrone—Myalgia—Pravastatin—atherosclerosis	0.000461	0.00267	CcSEcCtD
Mitoxantrone—Paraesthesia—Ezetimibe—atherosclerosis	0.00046	0.00267	CcSEcCtD
Mitoxantrone—Dyspepsia—Lovastatin—atherosclerosis	0.00046	0.00267	CcSEcCtD
Mitoxantrone—Anxiety—Pravastatin—atherosclerosis	0.000459	0.00266	CcSEcCtD
Mitoxantrone—Dyspnoea—Ezetimibe—atherosclerosis	0.000457	0.00265	CcSEcCtD
Mitoxantrone—Discomfort—Pravastatin—atherosclerosis	0.000456	0.00264	CcSEcCtD
Mitoxantrone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000454	0.00263	CcSEcCtD
Mitoxantrone—Decreased appetite—Lovastatin—atherosclerosis	0.000454	0.00263	CcSEcCtD
Mitoxantrone—Dyspepsia—Ezetimibe—atherosclerosis	0.000451	0.00262	CcSEcCtD
Mitoxantrone—Fatigue—Lovastatin—atherosclerosis	0.000451	0.00261	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Niacin—atherosclerosis	0.000449	0.0026	CcSEcCtD
Mitoxantrone—Oedema—Niacin—atherosclerosis	0.000449	0.0026	CcSEcCtD
Mitoxantrone—Pain—Lovastatin—atherosclerosis	0.000447	0.00259	CcSEcCtD
Mitoxantrone—Constipation—Lovastatin—atherosclerosis	0.000447	0.00259	CcSEcCtD
Mitoxantrone—Confusional state—Pravastatin—atherosclerosis	0.000446	0.00258	CcSEcCtD
Mitoxantrone—Decreased appetite—Ezetimibe—atherosclerosis	0.000446	0.00258	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000445	0.00258	CcSEcCtD
Mitoxantrone—Asthenia—Rosuvastatin—atherosclerosis	0.000443	0.00257	CcSEcCtD
Mitoxantrone—Oedema—Pravastatin—atherosclerosis	0.000442	0.00256	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000442	0.00256	CcSEcCtD
Mitoxantrone—Fatigue—Ezetimibe—atherosclerosis	0.000442	0.00256	CcSEcCtD
Mitoxantrone—Shock—Niacin—atherosclerosis	0.000442	0.00256	CcSEcCtD
Mitoxantrone—Infection—Pravastatin—atherosclerosis	0.000439	0.00255	CcSEcCtD
Mitoxantrone—Paraesthesia—Simvastatin—atherosclerosis	0.000439	0.00255	CcSEcCtD
Mitoxantrone—Constipation—Ezetimibe—atherosclerosis	0.000438	0.00254	CcSEcCtD
Mitoxantrone—Pain—Ezetimibe—atherosclerosis	0.000438	0.00254	CcSEcCtD
Mitoxantrone—Tachycardia—Niacin—atherosclerosis	0.000438	0.00254	CcSEcCtD
Mitoxantrone—Skin disorder—Niacin—atherosclerosis	0.000436	0.00253	CcSEcCtD
Mitoxantrone—Dyspnoea—Simvastatin—atherosclerosis	0.000436	0.00253	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Niacin—atherosclerosis	0.000434	0.00252	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000433	0.00251	CcSEcCtD
Mitoxantrone—Feeling abnormal—Lovastatin—atherosclerosis	0.000431	0.0025	CcSEcCtD
Mitoxantrone—SLC47A1—adipose tissue—atherosclerosis	0.00043	0.0405	CbGeAlD
Mitoxantrone—Dyspepsia—Simvastatin—atherosclerosis	0.00043	0.0025	CcSEcCtD
Mitoxantrone—Anorexia—Niacin—atherosclerosis	0.000428	0.00248	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000427	0.00248	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000427	0.00248	CcSEcCtD
Mitoxantrone—Decreased appetite—Simvastatin—atherosclerosis	0.000425	0.00246	CcSEcCtD
Mitoxantrone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000422	0.00245	CcSEcCtD
Mitoxantrone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000422	0.00245	CcSEcCtD
Mitoxantrone—Fatigue—Simvastatin—atherosclerosis	0.000422	0.00244	CcSEcCtD
Mitoxantrone—Anorexia—Pravastatin—atherosclerosis	0.000421	0.00244	CcSEcCtD
Mitoxantrone—Hypotension—Niacin—atherosclerosis	0.000419	0.00243	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000419	0.00243	CcSEcCtD
Mitoxantrone—Constipation—Simvastatin—atherosclerosis	0.000418	0.00242	CcSEcCtD
Mitoxantrone—Pain—Simvastatin—atherosclerosis	0.000418	0.00242	CcSEcCtD
Mitoxantrone—Urticaria—Lovastatin—atherosclerosis	0.000415	0.00241	CcSEcCtD
Mitoxantrone—Body temperature increased—Lovastatin—atherosclerosis	0.000413	0.0024	CcSEcCtD
Mitoxantrone—Abdominal pain—Lovastatin—atherosclerosis	0.000413	0.0024	CcSEcCtD
Mitoxantrone—CYP1B1—connective tissue—atherosclerosis	0.000411	0.0387	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000409	0.00237	CcSEcCtD
Mitoxantrone—Urticaria—Ezetimibe—atherosclerosis	0.000407	0.00236	CcSEcCtD
Mitoxantrone—Body temperature increased—Ezetimibe—atherosclerosis	0.000405	0.00235	CcSEcCtD
Mitoxantrone—Abdominal pain—Ezetimibe—atherosclerosis	0.000405	0.00235	CcSEcCtD
Mitoxantrone—Paraesthesia—Niacin—atherosclerosis	0.000403	0.00234	CcSEcCtD
Mitoxantrone—Feeling abnormal—Simvastatin—atherosclerosis	0.000403	0.00234	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000403	0.00233	CcSEcCtD
Mitoxantrone—Dyspnoea—Niacin—atherosclerosis	0.0004	0.00232	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0004	0.00232	CcSEcCtD
Mitoxantrone—Somnolence—Niacin—atherosclerosis	0.000399	0.00231	CcSEcCtD
Mitoxantrone—Paraesthesia—Pravastatin—atherosclerosis	0.000397	0.0023	CcSEcCtD
Mitoxantrone—Dyspepsia—Niacin—atherosclerosis	0.000395	0.00229	CcSEcCtD
Mitoxantrone—Dyspnoea—Pravastatin—atherosclerosis	0.000394	0.00228	CcSEcCtD
Mitoxantrone—Decreased appetite—Niacin—atherosclerosis	0.00039	0.00226	CcSEcCtD
Mitoxantrone—Dyspepsia—Pravastatin—atherosclerosis	0.000389	0.00226	CcSEcCtD
Mitoxantrone—Rash—Rosuvastatin—atherosclerosis	0.000389	0.00225	CcSEcCtD
Mitoxantrone—Dermatitis—Rosuvastatin—atherosclerosis	0.000389	0.00225	CcSEcCtD
Mitoxantrone—Urticaria—Simvastatin—atherosclerosis	0.000388	0.00225	CcSEcCtD
Mitoxantrone—Abdominal pain—Simvastatin—atherosclerosis	0.000386	0.00224	CcSEcCtD
Mitoxantrone—Body temperature increased—Simvastatin—atherosclerosis	0.000386	0.00224	CcSEcCtD
Mitoxantrone—Headache—Rosuvastatin—atherosclerosis	0.000386	0.00224	CcSEcCtD
Mitoxantrone—Hypersensitivity—Lovastatin—atherosclerosis	0.000385	0.00223	CcSEcCtD
Mitoxantrone—Decreased appetite—Pravastatin—atherosclerosis	0.000384	0.00223	CcSEcCtD
Mitoxantrone—Pain—Niacin—atherosclerosis	0.000384	0.00223	CcSEcCtD
Mitoxantrone—Fatigue—Pravastatin—atherosclerosis	0.000381	0.00221	CcSEcCtD
Mitoxantrone—Constipation—Pravastatin—atherosclerosis	0.000378	0.00219	CcSEcCtD
Mitoxantrone—Pain—Pravastatin—atherosclerosis	0.000378	0.00219	CcSEcCtD
Mitoxantrone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000378	0.00219	CcSEcCtD
Mitoxantrone—Asthenia—Lovastatin—atherosclerosis	0.000375	0.00217	CcSEcCtD
Mitoxantrone—Asthenia—Ezetimibe—atherosclerosis	0.000368	0.00213	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Niacin—atherosclerosis	0.000367	0.00213	CcSEcCtD
Mitoxantrone—Nausea—Rosuvastatin—atherosclerosis	0.000366	0.00212	CcSEcCtD
Mitoxantrone—Feeling abnormal—Pravastatin—atherosclerosis	0.000364	0.00211	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000361	0.0021	CcSEcCtD
Mitoxantrone—Hypersensitivity—Simvastatin—atherosclerosis	0.00036	0.00209	CcSEcCtD
Mitoxantrone—CYP1B1—cardiovascular system—atherosclerosis	0.000358	0.0337	CbGeAlD
Mitoxantrone—Diarrhoea—Lovastatin—atherosclerosis	0.000358	0.00207	CcSEcCtD
Mitoxantrone—Urticaria—Niacin—atherosclerosis	0.000357	0.00207	CcSEcCtD
Mitoxantrone—Abdominal pain—Niacin—atherosclerosis	0.000355	0.00206	CcSEcCtD
Mitoxantrone—Body temperature increased—Niacin—atherosclerosis	0.000355	0.00206	CcSEcCtD
Mitoxantrone—Urticaria—Pravastatin—atherosclerosis	0.000351	0.00204	CcSEcCtD
Mitoxantrone—Asthenia—Simvastatin—atherosclerosis	0.000351	0.00203	CcSEcCtD
Mitoxantrone—Diarrhoea—Ezetimibe—atherosclerosis	0.000351	0.00203	CcSEcCtD
Mitoxantrone—Abdominal pain—Pravastatin—atherosclerosis	0.000349	0.00203	CcSEcCtD
Mitoxantrone—Body temperature increased—Pravastatin—atherosclerosis	0.000349	0.00203	CcSEcCtD
Mitoxantrone—Diarrhoea—Simvastatin—atherosclerosis	0.000335	0.00194	CcSEcCtD
Mitoxantrone—Vomiting—Lovastatin—atherosclerosis	0.000332	0.00193	CcSEcCtD
Mitoxantrone—Hypersensitivity—Niacin—atherosclerosis	0.000331	0.00192	CcSEcCtD
Mitoxantrone—Rash—Lovastatin—atherosclerosis	0.00033	0.00191	CcSEcCtD
Mitoxantrone—Dermatitis—Lovastatin—atherosclerosis	0.000329	0.00191	CcSEcCtD
Mitoxantrone—Headache—Lovastatin—atherosclerosis	0.000327	0.0019	CcSEcCtD
Mitoxantrone—Vomiting—Ezetimibe—atherosclerosis	0.000326	0.00189	CcSEcCtD
Mitoxantrone—Hypersensitivity—Pravastatin—atherosclerosis	0.000326	0.00189	CcSEcCtD
Mitoxantrone—Rash—Ezetimibe—atherosclerosis	0.000323	0.00187	CcSEcCtD
Mitoxantrone—Dermatitis—Ezetimibe—atherosclerosis	0.000323	0.00187	CcSEcCtD
Mitoxantrone—Asthenia—Niacin—atherosclerosis	0.000322	0.00187	CcSEcCtD
Mitoxantrone—Headache—Ezetimibe—atherosclerosis	0.000321	0.00186	CcSEcCtD
Mitoxantrone—Asthenia—Pravastatin—atherosclerosis	0.000317	0.00184	CcSEcCtD
Mitoxantrone—CYP1B1—adipose tissue—atherosclerosis	0.000315	0.0297	CbGeAlD
Mitoxantrone—Vomiting—Simvastatin—atherosclerosis	0.000311	0.0018	CcSEcCtD
Mitoxantrone—Nausea—Lovastatin—atherosclerosis	0.00031	0.0018	CcSEcCtD
Mitoxantrone—Rash—Simvastatin—atherosclerosis	0.000308	0.00179	CcSEcCtD
Mitoxantrone—Dermatitis—Simvastatin—atherosclerosis	0.000308	0.00179	CcSEcCtD
Mitoxantrone—Diarrhoea—Niacin—atherosclerosis	0.000307	0.00178	CcSEcCtD
Mitoxantrone—Headache—Simvastatin—atherosclerosis	0.000306	0.00178	CcSEcCtD
Mitoxantrone—Nausea—Ezetimibe—atherosclerosis	0.000305	0.00177	CcSEcCtD
Mitoxantrone—Diarrhoea—Pravastatin—atherosclerosis	0.000302	0.00175	CcSEcCtD
Mitoxantrone—SLC47A1—liver—atherosclerosis	0.000302	0.0284	CbGeAlD
Mitoxantrone—ABCB1—blood vessel—atherosclerosis	0.000294	0.0277	CbGeAlD
Mitoxantrone—Nausea—Simvastatin—atherosclerosis	0.00029	0.00168	CcSEcCtD
Mitoxantrone—Vomiting—Niacin—atherosclerosis	0.000285	0.00165	CcSEcCtD
Mitoxantrone—ABCC1—adipose tissue—atherosclerosis	0.000284	0.0267	CbGeAlD
Mitoxantrone—Rash—Niacin—atherosclerosis	0.000283	0.00164	CcSEcCtD
Mitoxantrone—Dermatitis—Niacin—atherosclerosis	0.000283	0.00164	CcSEcCtD
Mitoxantrone—Headache—Niacin—atherosclerosis	0.000281	0.00163	CcSEcCtD
Mitoxantrone—Vomiting—Pravastatin—atherosclerosis	0.000281	0.00163	CcSEcCtD
Mitoxantrone—Rash—Pravastatin—atherosclerosis	0.000279	0.00162	CcSEcCtD
Mitoxantrone—Dermatitis—Pravastatin—atherosclerosis	0.000278	0.00161	CcSEcCtD
Mitoxantrone—Headache—Pravastatin—atherosclerosis	0.000277	0.00161	CcSEcCtD
Mitoxantrone—Nausea—Niacin—atherosclerosis	0.000267	0.00155	CcSEcCtD
Mitoxantrone—Nausea—Pravastatin—atherosclerosis	0.000263	0.00152	CcSEcCtD
Mitoxantrone—ABCG2—adipose tissue—atherosclerosis	0.000235	0.0221	CbGeAlD
Mitoxantrone—CYP2E1—cardiovascular system—atherosclerosis	0.000231	0.0217	CbGeAlD
Mitoxantrone—CYP1B1—liver—atherosclerosis	0.000221	0.0208	CbGeAlD
Mitoxantrone—ABCC1—liver—atherosclerosis	0.000199	0.0187	CbGeAlD
Mitoxantrone—ABCG2—liver—atherosclerosis	0.000165	0.0155	CbGeAlD
Mitoxantrone—CYP2E1—liver—atherosclerosis	0.000143	0.0134	CbGeAlD
Mitoxantrone—ABCB1—cardiovascular system—atherosclerosis	0.000131	0.0124	CbGeAlD
Mitoxantrone—ABCB1—adipose tissue—atherosclerosis	0.000116	0.0109	CbGeAlD
Mitoxantrone—CYP3A4—liver—atherosclerosis	0.000115	0.0108	CbGeAlD
Mitoxantrone—ABCB1—liver—atherosclerosis	8.12e-05	0.00765	CbGeAlD
Mitoxantrone—BTK—Innate Immune System—IL6—atherosclerosis	2.66e-05	0.000198	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—atherosclerosis	2.64e-05	0.000197	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CETP—atherosclerosis	2.63e-05	0.000196	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SCARB1—atherosclerosis	2.61e-05	0.000194	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.54e-05	0.000189	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.53e-05	0.000188	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SCARB1—atherosclerosis	2.52e-05	0.000187	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NAMPT—atherosclerosis	2.5e-05	0.000186	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—LIPC—atherosclerosis	2.48e-05	0.000185	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP27A1—atherosclerosis	2.48e-05	0.000184	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK3—atherosclerosis	2.48e-05	0.000184	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOC3—atherosclerosis	2.47e-05	0.000183	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NFKB1—atherosclerosis	2.47e-05	0.000183	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMGCR—atherosclerosis	2.46e-05	0.000183	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.45e-05	0.000183	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—LDLR—atherosclerosis	2.45e-05	0.000182	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—atherosclerosis	2.45e-05	0.000182	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.44e-05	0.000181	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK8—atherosclerosis	2.42e-05	0.00018	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.41e-05	0.000179	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CETP—atherosclerosis	2.39e-05	0.000178	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMGCR—atherosclerosis	2.38e-05	0.000177	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—atherosclerosis	2.35e-05	0.000175	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	2.35e-05	0.000175	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOA2—atherosclerosis	2.35e-05	0.000175	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	2.35e-05	0.000175	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALOX15—atherosclerosis	2.35e-05	0.000175	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCG5—atherosclerosis	2.32e-05	0.000173	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SCARB1—atherosclerosis	2.29e-05	0.000171	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LPA—atherosclerosis	2.24e-05	0.000167	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCG1—atherosclerosis	2.23e-05	0.000166	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.22e-05	0.000165	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—atherosclerosis	2.22e-05	0.000165	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.2e-05	0.000163	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCA1—atherosclerosis	2.19e-05	0.000163	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BGN—atherosclerosis	2.17e-05	0.000162	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMGCR—atherosclerosis	2.17e-05	0.000161	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.16e-05	0.00016	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOB—atherosclerosis	2.15e-05	0.00016	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOA5—atherosclerosis	2.15e-05	0.00016	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.15e-05	0.00016	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.13e-05	0.000159	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.12e-05	0.000158	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCA1—atherosclerosis	2.12e-05	0.000158	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK3—atherosclerosis	2.12e-05	0.000157	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LCAT—atherosclerosis	2.1e-05	0.000156	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FABP4—atherosclerosis	2.1e-05	0.000156	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.07e-05	0.000154	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	2.07e-05	0.000154	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOA4—atherosclerosis	2.06e-05	0.000153	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—LPL—atherosclerosis	2.06e-05	0.000153	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.02e-05	0.00015	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLTP—atherosclerosis	2e-05	0.000149	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALOX5—atherosclerosis	2e-05	0.000149	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRKCG—atherosclerosis	2e-05	0.000149	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.99e-05	0.000148	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCA1—atherosclerosis	1.93e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.91e-05	0.000142	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.88e-05	0.00014	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMOX1—atherosclerosis	1.88e-05	0.00014	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.87e-05	0.000139	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—atherosclerosis	1.85e-05	0.000138	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.83e-05	0.000136	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.83e-05	0.000136	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMOX1—atherosclerosis	1.82e-05	0.000135	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOB—atherosclerosis	1.8e-05	0.000134	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PDGFB—atherosclerosis	1.8e-05	0.000134	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NAMPT—atherosclerosis	1.79e-05	0.000133	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LIPC—atherosclerosis	1.78e-05	0.000133	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOC3—atherosclerosis	1.77e-05	0.000132	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALOX15—atherosclerosis	1.77e-05	0.000132	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.77e-05	0.000132	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.77e-05	0.000132	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOA2—atherosclerosis	1.77e-05	0.000132	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LDLR—atherosclerosis	1.76e-05	0.000131	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTM1—atherosclerosis	1.75e-05	0.00013	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCG5—atherosclerosis	1.75e-05	0.00013	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOB—atherosclerosis	1.74e-05	0.00013	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.74e-05	0.000129	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.74e-05	0.000129	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOE—atherosclerosis	1.72e-05	0.000128	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—LPL—atherosclerosis	1.72e-05	0.000128	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CETP—atherosclerosis	1.72e-05	0.000128	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.71e-05	0.000127	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CAV1—atherosclerosis	1.71e-05	0.000127	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APOA1—atherosclerosis	1.7e-05	0.000127	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—atherosclerosis	1.7e-05	0.000126	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LPA—atherosclerosis	1.69e-05	0.000126	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GPX1—atherosclerosis	1.68e-05	0.000125	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—LPL—atherosclerosis	1.67e-05	0.000124	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMOX1—atherosclerosis	1.66e-05	0.000123	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SCARB1—atherosclerosis	1.65e-05	0.000122	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BGN—atherosclerosis	1.64e-05	0.000122	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CD36—atherosclerosis	1.64e-05	0.000122	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GPX1—atherosclerosis	1.62e-05	0.000121	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOA5—atherosclerosis	1.62e-05	0.00012	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—atherosclerosis	1.61e-05	0.000119	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOB—atherosclerosis	1.59e-05	0.000118	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CD36—atherosclerosis	1.58e-05	0.000118	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.56e-05	0.000116	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.55e-05	0.000116	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—atherosclerosis	1.55e-05	0.000115	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—atherosclerosis	1.55e-05	0.000115	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.54e-05	0.000115	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—atherosclerosis	1.54e-05	0.000115	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARA—atherosclerosis	1.52e-05	0.000113	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—LPL—atherosclerosis	1.51e-05	0.000113	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALOX5—atherosclerosis	1.51e-05	0.000112	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—atherosclerosis	1.5e-05	0.000111	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPX1—atherosclerosis	1.48e-05	0.00011	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AGT—atherosclerosis	1.47e-05	0.00011	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—INS—atherosclerosis	1.47e-05	0.000109	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARA—atherosclerosis	1.47e-05	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.45e-05	0.000108	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOE—atherosclerosis	1.44e-05	0.000107	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CD36—atherosclerosis	1.44e-05	0.000107	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CAV1—atherosclerosis	1.43e-05	0.000106	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—atherosclerosis	1.43e-05	0.000106	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—APOA1—atherosclerosis	1.43e-05	0.000106	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AGT—atherosclerosis	1.42e-05	0.000106	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOE—atherosclerosis	1.4e-05	0.000104	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.39e-05	0.000103	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CAV1—atherosclerosis	1.38e-05	0.000103	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APOA1—atherosclerosis	1.38e-05	0.000103	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.37e-05	0.000102	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—atherosclerosis	1.36e-05	0.000101	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SERPINE1—atherosclerosis	1.35e-05	0.000101	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NAMPT—atherosclerosis	1.35e-05	0.0001	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LIPC—atherosclerosis	1.34e-05	9.98e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARA—atherosclerosis	1.34e-05	9.95e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOC3—atherosclerosis	1.33e-05	9.92e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LDLR—atherosclerosis	1.33e-05	9.86e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.3e-05	9.69e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AGT—atherosclerosis	1.3e-05	9.64e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CETP—atherosclerosis	1.29e-05	9.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FABP4—atherosclerosis	1.29e-05	9.6e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LCAT—atherosclerosis	1.29e-05	9.6e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—atherosclerosis	1.29e-05	9.6e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.27e-05	9.45e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOE—atherosclerosis	1.27e-05	9.44e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOA4—atherosclerosis	1.27e-05	9.43e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—atherosclerosis	1.26e-05	9.37e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAV1—atherosclerosis	1.26e-05	9.36e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—atherosclerosis	1.26e-05	9.35e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APOA1—atherosclerosis	1.26e-05	9.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.25e-05	9.26e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SCARB1—atherosclerosis	1.24e-05	9.22e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—INS—atherosclerosis	1.23e-05	9.17e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—atherosclerosis	1.22e-05	9.04e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—INS—atherosclerosis	1.19e-05	8.87e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.19e-05	8.84e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—atherosclerosis	1.18e-05	8.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMGCR—atherosclerosis	1.17e-05	8.71e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.15e-05	8.56e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.15e-05	8.54e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.15e-05	8.52e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOB—atherosclerosis	1.14e-05	8.47e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—atherosclerosis	1.13e-05	8.41e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.11e-05	8.24e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—atherosclerosis	1.11e-05	8.23e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—atherosclerosis	1.09e-05	8.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.09e-05	8.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.09e-05	8.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.09e-05	8.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.09e-05	8.11e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LPL—atherosclerosis	1.09e-05	8.09e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—INS—atherosclerosis	1.08e-05	8.07e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—atherosclerosis	1.08e-05	8.04e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.08e-05	8.01e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPX1—atherosclerosis	1.06e-05	7.89e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—atherosclerosis	1.05e-05	7.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCA1—atherosclerosis	1.04e-05	7.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LPA—atherosclerosis	1.04e-05	7.74e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CD36—atherosclerosis	1.03e-05	7.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BGN—atherosclerosis	1.01e-05	7.5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOA5—atherosclerosis	9.98e-06	7.42e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—atherosclerosis	9.94e-06	7.4e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—atherosclerosis	9.89e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—atherosclerosis	9.79e-06	7.28e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARA—atherosclerosis	9.61e-06	7.14e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.61e-06	7.14e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—atherosclerosis	9.56e-06	7.11e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—atherosclerosis	9.51e-06	7.07e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AGT—atherosclerosis	9.3e-06	6.92e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.28e-06	6.9e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—atherosclerosis	9.21e-06	6.85e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOE—atherosclerosis	9.12e-06	6.78e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAV1—atherosclerosis	9.03e-06	6.72e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APOA1—atherosclerosis	9.01e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—atherosclerosis	8.95e-06	6.66e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK3—atherosclerosis	8.8e-06	6.54e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—atherosclerosis	8.7e-06	6.47e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOB—atherosclerosis	8.58e-06	6.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—atherosclerosis	8.54e-06	6.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—atherosclerosis	8.34e-06	6.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.32e-06	6.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LIPC—atherosclerosis	8.27e-06	6.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—atherosclerosis	8.23e-06	6.12e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOC3—atherosclerosis	8.22e-06	6.11e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LPL—atherosclerosis	8.19e-06	6.09e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LDLR—atherosclerosis	8.17e-06	6.07e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPX1—atherosclerosis	7.99e-06	5.94e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CETP—atherosclerosis	7.98e-06	5.93e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—atherosclerosis	7.94e-06	5.91e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—INS—atherosclerosis	7.79e-06	5.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CD36—atherosclerosis	7.78e-06	5.79e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.64e-06	5.68e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—atherosclerosis	7.37e-06	5.48e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARA—atherosclerosis	7.23e-06	5.38e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.21e-06	5.37e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—atherosclerosis	7.14e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AGT—atherosclerosis	7.01e-06	5.21e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOE—atherosclerosis	6.86e-06	5.11e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—atherosclerosis	6.83e-06	5.08e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAV1—atherosclerosis	6.8e-06	5.06e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APOA1—atherosclerosis	6.79e-06	5.05e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—atherosclerosis	6.43e-06	4.78e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.43e-06	4.78e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—atherosclerosis	6.25e-06	4.65e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.2e-06	4.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—atherosclerosis	5.98e-06	4.45e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—atherosclerosis	5.93e-06	4.41e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—INS—atherosclerosis	5.86e-06	4.36e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.52e-06	4.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—atherosclerosis	5.38e-06	4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOB—atherosclerosis	5.28e-06	3.93e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—atherosclerosis	5.14e-06	3.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.14e-06	3.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LPL—atherosclerosis	5.05e-06	3.75e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—atherosclerosis	4.97e-06	3.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX1—atherosclerosis	4.92e-06	3.66e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—atherosclerosis	4.81e-06	3.57e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CD36—atherosclerosis	4.79e-06	3.57e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—atherosclerosis	4.7e-06	3.5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.54e-06	3.38e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARA—atherosclerosis	4.46e-06	3.31e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—atherosclerosis	4.37e-06	3.25e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AGT—atherosclerosis	4.32e-06	3.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOE—atherosclerosis	4.23e-06	3.15e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAV1—atherosclerosis	4.19e-06	3.12e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APOA1—atherosclerosis	4.18e-06	3.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.82e-06	2.84e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—atherosclerosis	3.68e-06	2.74e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—INS—atherosclerosis	3.61e-06	2.69e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—atherosclerosis	3.31e-06	2.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—atherosclerosis	3.17e-06	2.36e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—atherosclerosis	3.14e-06	2.33e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.9e-06	2.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—atherosclerosis	2.36e-06	1.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.46e-06	1.08e-05	CbGpPWpGaD
